Competition

  • January 26, 2026

    Truck Makers Say Calif. Delaying 'Clean Trucks Pact' Fight

    Heavy-duty truck manufacturers on Monday accused California officials of trying to delay litigation over a 2023 agreement that would saddle manufacturers with stringent state emissions standards and stiff penalties for noncompliance in the coming years.

  • January 26, 2026

    Fubo Subscribers Defend Streaming Rate Suit Against Disney

    A proposed class of Fubo subscribers is opposing a bid from Disney to force them to arbitrate their claims in an antitrust case alleging streaming services pay inflated rates to carry ESPN and other sports channels.

  • January 26, 2026

    Google Targets Publishers' Ad Tech Claims

    Google asked a New York federal judge to cut out a wide swath of antitrust claims from multidistrict litigation targeting its advertising placement technology dominance, assailing in separate briefs allegations from a class of website publishers and from the Daily Mail and Gannett.

  • January 26, 2026

    9th Circ. Pauses Discovery Order In UFC Wage Suits

    A Ninth Circuit panel temporarily paused a Nevada federal court's discovery order in wage suppression lawsuits against UFC after the mixed martial arts organization said the order violated attorney-client privilege and the First Amendment.

  • January 26, 2026

    Amex Seeks First Approval Of $17M Antisteering Settlement

    American Express Co. has asked a New York federal judge to grant the first green light to a $17.5 million settlement reached with consumers who claimed the credit card company's so-called antisteering rules caused non-Amex cardholders to pay higher charges, after a New York federal jury ordered Amex to pay $12 million to one class of consumers.

  • January 26, 2026

    Novo Nordisk Faces Class Claims Over GLP-1 Patent Tactics

    A South Carolina drug company has launched a proposed class action against major pharmaceutical company Novo Nordisk, alleging it engaged in anticompetitive behavior to prolong its monopoly against generic competition for the GLP-1 drug Victoza.

  • January 26, 2026

    Radio Co. Says Letting Nielsen Resume Data Tying Hurts Biz

    Cumulus Media has urged the Second Circuit not to lift a New York federal judge's order blocking Nielsen from conditioning access to its nationwide radio ratings data on the purchase of local market data while the ratings company appeals the ruling.

  • January 26, 2026

    Remote Discovery Tech Co. Alleges Fraud In Del. Suit

    A tech company that developed self-service applications for remote data collection from smartphones has launched a seven-count suit in Delaware's Court of Chancery accusing a product reseller of copying the application's functions and features and marketing competing versions.

  • January 26, 2026

    Calif. Gaming Org. Fights Tribe's Bid To Join $700M Casino Suit

    A District of Columbia federal judge on Monday granted the California Gaming Association's amicus brief bid to oppose a California Indian tribe's potential dismissal motion against another tribe's fight with the federal government over a $700 million casino project in Vallejo, California.

  • January 23, 2026

    Pro Swimming League Wins Antitrust Trial. Its Prize? $1

    A California federal jury has determined that World Aquatics illegally boycotted International Swimming League events in violation of federal antitrust law, but awarded just $1 in damages, in a verdict returned Friday.

  • January 23, 2026

    Mich. AG Sues Major Oil Co. 'Cartel' Amid Fight With DOJ

    Michigan Attorney General Dana Nessel filed an antitrust suit in federal court against BP, Shell, Chevron, Exxon and the American Petroleum Institute on Friday, claiming they conspired to maintain market dominance by steering money away from renewable energy and using a bevy of other tactics including intimidation and information suppression.

  • January 23, 2026

    CLO Investors Accused Of Rigging Rates In Shift From Libor

    Major equity investors in collateralized loan obligations have been sued in Connecticut federal court over claims that they colluded to force corporate leveraged-loan borrowers to accept higher interest rates during the phaseout of the London Interbank Offered Rate, or Libor.

  • January 23, 2026

    High Court Unlikely To Walk Back MLB's Antitrust Privilege

    Baseball's status as the lone sport exempt from federal antitrust laws is likely to evade U.S. Supreme Court scrutiny, with legal experts saying that only an extraordinary challenge could make justices even consider it.

  • January 23, 2026

    Providers Oppose Credit Bureaus' Medical Debt Appeal

    A proposed class of medical providers and collection agencies accusing Equifax, Experian and TransUnion of colluding to exclude medical debt under $500 from consumer credit reports is opposing a bid by the credit bureaus to expedite an appeal of a ruling that denied dismissal of the claims.

  • January 23, 2026

    NCAA Player Can't Rush Eligibility Order, Judge Says

    A Florida federal judge recommended denying a request by a university basketball player to expedite an injunction allowing her to play a fifth season, finding the National College Athletic Association wasn't inconsistent with denying eligibility.

  • January 23, 2026

    Heart Valve Deal Was Blocked Over Innovation Concerns

    The D.C. federal court ruling earlier this month that upended a deal for Edwards Lifesciences Corp. to purchase JenaValve Technology Inc. was based on concerns that the deal would reduce innovation by eliminating competition for a heart valve treatment that's still being developed, according to a ruling unsealed on Friday by the judge who issued it.

  • January 23, 2026

    $200M Sun, Taro Generics Deal Gets Final OK

    A Pennsylvania federal judge granted final approval Friday for a $200 million deal resolving employee benefits plans' claims against Sun Pharmaceutical and Taro Pharmaceuticals in the sprawling price-fixing litigation against generic-drug makers, while again ensuring the claims from dozens of state attorneys general remain untouched by the settlement.

  • January 23, 2026

    How Data, Pies And An FTC Twist Helped Close A $13B Deal

    For the Willkie Farr & Gallagher LLP attorneys advising The Interpublic Group of Companies Inc. on its blockbuster merger with Omnicom Group Inc., reaching the finish line came with an unusual antitrust concession: a Federal Trade Commission agreement aimed at the politics of ad placement.

  • January 23, 2026

    News Rating Org. Latest To Fight 'Ideological' FTC Subpoena

    News rating organization NewsGuard became the latest group to challenge a Federal Trade Commission subpoena looking for censorship of conservative viewpoints, asking the agency to quash information demands it said was born of FTC Chairman Andrew Ferguson's "ideologically motivated effort to censor and otherwise discriminate" against it.

  • January 23, 2026

    Commerce Hits Chinese Slag Pots With Duties

    The U.S. Department of Commerce hit imported slag pots from China with countervailing and antidumping duties Friday after the U.S. International Trade Commission had found the dumped and subsidized imports were causing material injury to domestic industry.

  • January 23, 2026

    Full 9th Circ. Won't Review Google Maps Antitrust Case

    The full Ninth Circuit won't reconsider an appellate panel's recent decision refusing to revive a proposed antitrust class action alleging Google's terms suppresses competition by locking out rival maps products and jacking up developer costs up to 1,400%, according to a brief order issued Thursday.

  • January 23, 2026

    FCC Considers Revoking Texas Radio Station Licenses

    The Federal Communications Commission has designated for hearing a proposed transfer of control involving three Texas radio stations, citing substantial questions about unauthorized foreign control, misrepresentations, and lack of candor that could ultimately lead to license revocation.

  • January 23, 2026

    X Can't Access OpenAI Source Code In Antitrust Suit

    A Texas federal court will not force OpenAI Inc. to hand over its source code in an antitrust case from Elon Musk's X Corp. over the artificial intelligence company's deal to integrate ChatGPT on Apple devices.

  • January 23, 2026

    More Push In The 'Push-Pull' As DOJ Targets 'Gamesmanship'

    The U.S. Department of Justice continues to build its task force targeting "gamesmanship" that it says BigLaw attorneys for major companies, especially technology platforms, are using to obstruct antitrust investigations — an effort that has been welcomed by some practitioners and questioned by others.

  • January 23, 2026

    Chancery Says Daxko Noncompete Is Unenforceable

    The Delaware Chancery Court has recommended dismissing a lawsuit brought by software company Daxko LLC and its parent Diamond Parent LP against a former sales executive, concluding that the sweeping noncompete agreement at the center of the dispute is unenforceable under Delaware law.

Expert Analysis

  • A Look At Robinson-Patman Enforcement In The MLM Industry

    Author Photo

    The Federal Trade Commission's recent focus on price discrimination in high-profile speeches and litigation suggests a renewed interest around Robinson-Patman Act enforcement, particularly in multilevel marketing, making it an apt time for direct sellers to audit their pricing, say Katrina Eash at Winston & Strawn and Juliet Belling Warren and Branko Jovanovic at Edgeworth Economics.

  • What 2 Profs Noticed As Transactional Law Students Used AI

    Author Photo

    After a semester using generative artificial intelligence tools with students in an entrepreneurship law clinic, we came away with numerous observations about the opportunities and challenges such tools present to new transactional lawyers, say professors at Cornell Law School.

  • State AGs Are Turning Up The Antitrust Heat On ESG Actions

    Author Photo

    Recent antitrust developments from red state attorneys general continue a trend of environmental, social and governance scrutiny, and businesses exposed to these areas should conduct close examinations of strategy and potential material risk, say attorneys at Morgan Lewis.

  • Rebuttal

    BigLaw Settlements Should Not Spur Ethics Deregulation

    Author Photo

    A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.

  • Opinion

    8th Circ. Should Reaffirm False Commercial Speech's Nature

    Author Photo

    The Eighth Circuit in Goldfinch Laboratory v. Iowa Pathology Associates should assert that false commercial speech is not categorically immune from antitrust scrutiny, says Daniel Graulich at the Federal Trade Commission.

  • How Big Pharma Has Responded To FTC Delisting Demands

    Author Photo

    Looking at some statistics concerning how pharmaceutical companies have responded to the Federal Trade Commission's recent challenges to Orange Book listings raises several possible hypotheses about the FTC's strategy and effectiveness, say Ratib Ali and Celia Lu at Competition Dynamics.

  • Unpacking Ore. Law's Limits On PE Healthcare Investment

    Author Photo

    A recent Oregon law imposes significant restrictions on nonphysicians owning or controlling medical practices, but newly enacted amendments provide some additional flexibility in certain ownership arrangements without scuttling the law's intent of addressing concerns about the rise of private equity investment in healthcare, say attorneys at Debevoise.

  • 5 Ways Lawyers Can Earn Back The Public's Trust

    Author Photo

    Amid salacious headlines about lawyers behaving badly and recent polls showing the public’s increasingly unfavorable view of attorneys, we must make meaningful changes to our culture to rebuild trust in the legal system, says Carl Taylor at Carl Taylor Law.

  • Class Actions At The Circuit Courts: August Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses key takeaways from federal appellate decisions involving topics including antitrust, immigration, consumer fraud, birthright citizenship under the Fourteenth Amendment, and product defects.

  • Series

    Hiking Makes Me A Better Lawyer

    Author Photo

    On the trail, I have thought often about the parallels between hiking and high-stakes patent litigation, and why strategizing, preparation, perseverance and joy are important skills for success in both endeavors, says Barbara Fiacco at Foley Hoag.

  • Series

    Law School's Missed Lessons: Negotiation Skills

    Author Photo

    I took one negotiation course in law school, but most of the techniques I rely on today I learned in practice, where I've discovered that the process is less about tricks or tactics, and more about clarity, preparation and communication, says Grant Schrantz at Haug Barron.

  • DOJ Whistleblower Program May Fuel Criminal Antitrust Tack

    Author Photo

    A recently launched Justice Department program that provides rewards for reporting antitrust crimes related to the U.S. Postal Service will serve to supplement the department’s leniency program, signaling an ambition to expand criminal enforcement while deepening collaboration across agencies, say attorneys at Crowell & Moring.

  • Opinion

    Bar Exam Reform Must Expand Beyond A Single Updated Test

    Author Photo

    Recently released information about the National Conference of Bar Examiners’ new NextGen Uniform Bar Exam highlights why a single test is not ideal for measuring newly licensed lawyers’ competency, demonstrating the need for collaborative development, implementation and reform processes, says Gregory Bordelon at Suffolk University.

  • A Simple Way Courts Can Help Attys Avoid AI Hallucinations

    Author Photo

    As attorneys increasingly rely on generative artificial intelligence for legal research, courts should consider expanding online quality control programs to flag potential hallucinations — permitting counsel to correct mistakes and sparing judges the burden of imposing sanctions, say attorneys at Lankler Siffert & Wohl and Connors.

  • Antitrust Scrutiny Heightens In The Cannabis Industry

    Author Photo

    Two ongoing antitrust cases signal intensified scrutiny of pricing practices, distribution restraints and exclusionary conduct in the cannabis sector, says Robin Crauthers at McCarter & English.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.